Morningstar's Tim Strauts details the complicated tax treatment of MLPs, commodities, and other nontraditional assets, and offers several ETF and ETN picks along with another to avoid.
Increased life sciences funding, declining consumer charge-offs, and underappreciated earnings power at big banks have made some ripe picks for investors.
Morningstar's Jaime Peters checks in on the current health and outlook for Citi, J.P. Morgan, and BofA following release of their second-quarter results.
Even though the eurozone crisis flared up again last week, there are still some values in the U.S. market that should be able to withstand the volatility.